Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Evaluation of the GORE® Ascending Stent Graft

NCT: NCT05800743 · ENROLLING_BY_INVITATION

NCT IDNCT05800743
StatusENROLLING_BY_INVITATION
Start Date2023-11-28
SponsorW.L.Gore & Associates (INDUSTRY)
First posted
Last updated

Brief Summary

The primary objective of ARISE II is to assess the safety and effectiveness of the GORE® Ascending Stent Graft device in the treatment of lesions involving the ascending aorta and aortic arch.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑